-
Amgen Eyeing Preclinical Blood Cancer Program to Its Skills
10 Jan 2026 13:25 GMT
- Advertisement -
Amgen is going ahead and adding … is concerned.
Via the buyout, Amgen gets the investigational small molecule … of R&D at Amgen, said that acute myeloid leukemia … the existing research organization of Amgen.
Dark Blue, which was founded …
-
US close: Dow and S&P 500 set new records, Nasdaq hits two-month high
10 Jan 2026 01:41 GMT
… peaks set on Tuesday. The Nasdaq, meanwhile, gained 1.0% to … ) $375.64 -1.92%
Amgen Inc. (AMGN) $326.10 -1.21%
Unitedhealth … . (MAT) $21.48 -3.07%
Nasdaq 100 - Risers
Asml Holdings … -2.32%
Vodafone Group Plc ADS (VOD) $13.50 -2.32% …
-
FDA untitled letter skewers Esperion’s claims about cholesterol med Nexlizet in TV ad
07 Jan 2026 22:13 GMT
… multiple aspects of the TV ad, including its use of … with their comprehension of the ad’s major statement about … criticized a claim in the ad’s voiceover and corresponding onscreen … approved for those purposes include Amgen’s Repatha and Regeneron and …
-
J&J's Tremfya outstrips AbbVie's Skyrizi again, closing out 2025 as December's top TV ad spender
07 Jan 2026 03:52 GMT
… and Genentech’s Xolair, Amgen’s Repatha and Bristol Myers … prime target for pharma brands’ ads, with all of the … three psoriatic arthritis)
Biggest-ticket ad: “Break Away: Relentless Weed” … of spots: One
Biggest-ticket ad: “Uncontrollable Movements” (est. $ …
-
Two new Untitled Letters, multiple close-outs: Latest on FDA’s pharma ad crackdown
11 Dec 2025 19:15 GMT
… ’s director of regulatory advertising and promotion policy Payal … resolved.
AstraZeneca, Takeda and Amgen were among the Big Pharma … company has discontinued the TV ads and other promotional materials, … Untitled Letter for its Farxiga ad — due to misleadingly …
-
US open: Dow slips, Nasdaq gains as Fed cut hopes linger
08 Dec 2025 20:42 GMT
… .20%
Dow Jones - Fallers
Amgen Inc. (AMGN) $322.42 -2.26% … ) $119.16 -2.68%
Amgen Inc. (AMGN) $322.42 -2.26%
Vertex … . (INTC) $40.81 -1.44%
Nasdaq 100 - Risers
Wynn Resorts … .26 -1.97%
NetEase Inc. Ads (NTES) $137.12 -1.91% …
-
Amgen Inc. (NASDAQ:AMGN) Q3 2025 Earnings Call Transcript
06 Nov 2025 13:27 GMT
… an adequate efficacy at an ad hoc analysis requested by the … &A Session
Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) Receive real-time … may now disconnect.
Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) Receive real-time …
-
AbbVie revs up Skyrizi spending to top TV ad totals in November, edging out J&J's Tremfya
05 Dec 2025 19:48 GMT
… .3 million to air TV ads for the top 10 brands … .5 million into airing their ads, for a year-over-year … reactions to certain foods, and Amgen’s decade-old cholesterol med … is it? Amgen’s cholesterol drug
Est. national TV ad spend: $17 …
-
AstraZeneca receives latest Untitled Letter from FDA for Farxiga ad
17 Nov 2025 18:28 GMT
… faulted AstraZeneca for an ad promoting Farixga, its medication … in the division of advertising and promotion review at … directed at companies including AbbVie, Amgen, Takeda and Novartis — weeks … received three warnings for ads promoting add-on asthma …
-
Survey reveals 'cardiology deserts' at heart of Amgen-backed campaign
15 Nov 2025 00:57 GMT
… campaign in these “cardiology deserts.”
Amgen put up seed sponsorship support … , M.D., Ph.D., Amgen’s chief medical officer, said … Media Network set up an ad market to help companies reach … funding heart health equity work.
Amgen, which sells the PCSK9 …